Evaluating the safety and efficacy of ustekinumab maintenance therapy in subjects with moderately to severely active Crohn’s disease. This clinical trial continues from the induction study comparing ustekinumab vs. placebo to study maintenance of the drug over 3 years. Janssen Research & Development

Evaluating efficacy and safety of SAR339658 in patients with active moderate to severe ulcerative colitis (UC). This randomized trial compares placebo to an intravenous treatment for ulcerative colitis. Sanofi US Services Inc.

Oral CP-690,550 as an induction therapy in subjects with moderate to severe ulcerative colitis. This randomized trial compares placebo to an investigational oral medication for ulcerative colitis. Pfizer

Retrospective review of effect of positional modifications on gastric transit time after oral ingestion of WCE in pediatric patients. University of Rochester, Golisano Children's Hospital, August 2014 – present.